000161099 001__ 161099
000161099 005__ 20251017144633.0
000161099 0247_ $$2doi$$a10.3389/fmed.2025.1473619
000161099 0248_ $$2sideral$$a144225
000161099 037__ $$aART-2025-144225
000161099 041__ $$aeng
000161099 100__ $$0(orcid)0000-0002-1275-2600$$aSantander, S.$$uUniversidad de Zaragoza
000161099 245__ $$aEpidemiology and factors associated with the perioperative course of patients undergoing hip fracture during the initial phase of the state of emergency declared in 2020
000161099 260__ $$c2025
000161099 5060_ $$aAccess copy available to the general public$$fUnrestricted
000161099 5203_ $$aIntroductionCurrently, there is no gold standard anesthetic plan for elderly patients with hip fractures who must undergo surgery. The state of alarm during 2020 due to the COVID-19 pandemic changed certain hospital paradigms, prompting an investigation into differences in anesthetic management and patient survival for hip fracture surgeries using gamma nail osteosynthesis in 2020 compared to 2019.Materials and methodsA historical cohort study was conducted to assess morbidity and mortality, with data obtained from anonymized medical records.ResultsStatistically significant differences were found, notably an increase in Body Mass Index during confinement. A statistically significant decrease in leukocyte and hemoglobin levels was observed after surgery. However, there were no statistically significant differences in mortality between 2019 and 2020. Patients who did not require vasoactive drugs during surgery to maintain blood pressure levels above 90/60 mmHg had a better survival rate.ConclusionDespite the reduction in postoperative hospital surveillance time, no increase in complications was found. This allowed for early patient reintegration into daily life, early functional rehabilitation, and the minimization of economic costs.
000161099 536__ $$9info:eu-repo/grantAgreement/ES/DGA/A05-23R
000161099 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttps://creativecommons.org/licenses/by/4.0/deed.es
000161099 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000161099 700__ $$aLanuza, A.$$uUniversidad de Zaragoza
000161099 700__ $$0(orcid)0000-0002-3647-5679$$aLongás, J.$$uUniversidad de Zaragoza
000161099 700__ $$aÚbeda, F.
000161099 700__ $$aMarco, C.
000161099 700__ $$0(orcid)0000-0003-4071-1467$$aLuesma, M. J.$$uUniversidad de Zaragoza
000161099 7102_ $$11003$$2027$$aUniversidad de Zaragoza$$bDpto. Anatom.Histolog.Humanas$$cArea Anatom.Embriol.Humana
000161099 7102_ $$11012$$2315$$aUniversidad de Zaragoza$$bDpto. Farmac.Fisiol.y Med.L.F.$$cÁrea Farmacología
000161099 7102_ $$11013$$2090$$aUniversidad de Zaragoza$$bDpto. Cirugía$$cÁrea Cirugía
000161099 773__ $$g12 (2025), 1473619 [10 pp.]$$pFront. med.$$tFrontiers in Medicine$$x2296-858X
000161099 8564_ $$s555335$$uhttps://zaguan.unizar.es/record/161099/files/texto_completo.pdf$$yVersión publicada
000161099 8564_ $$s2034895$$uhttps://zaguan.unizar.es/record/161099/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000161099 909CO $$ooai:zaguan.unizar.es:161099$$particulos$$pdriver
000161099 951__ $$a2025-10-17-14:27:11
000161099 980__ $$aARTICLE